Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Omar F AbouEzzeddine

Showing results (1-10 of 49) with videos related to

Pageof 5
Sort By:
Congestive Heart Failure (Greenwich, Conn.)|July 28, 2011
Who has advanced heart failure?: definition and epidemiologyOmar F Abouezzeddine, Margaret M Redfield
Frontiers in Neurology|February 19, 2021
Chloroquine and Hydroxychloroquine Myopathy: Clinical Spectrum and Treatment OutcomesElie Naddaf, Pritikanta Paul, Omar F AbouEzzeddine
Plos One|August 17, 2018
High-sensitivity C-reactive protein in heart failure with preserved ejection fractionHilary M DuBrock, Omar F AbouEzzeddine, Margaret M Redfield
The Quarterly Journal of Nuclear Medicine and Molecular Imaging : Official Publication of the Italian Association of Nuclear Medicine (AIMN) [And] the International Association of Radiopharmacology (IAR), [And] Section of the Society Of|January 30, 2020
Imaging cardiac sarcoidosis and infiltrative diseases: diagnosis and therapeutic responseMohamed Y Elwazir, John P Bois, Omar F Abouezzeddine, et al.
Internal and Emergency Medicine|May 17, 2026
Novelty to necessity: large language models in clinical practice-a call to action for physiciansVittorio Beltrani, Olivier Giannini, Omar F AbouEzzeddine, et al.
Biomarkers : Biochemical Indicators of Exposure, Response, and Susceptibility to Chemicals|July 16, 2021
Sex-specific cut-off values for soluble suppression of tumorigenicity 2 (ST2) biomarker increase its cardiovascular prognostic value in the communityDavid M Harmon, Omar F AbouEzzeddine, Paul M McKie, et al.
Transplantation|April 21, 2018
Outcomes After Cardiac Transplant for Wild Type Transthyretin AmyloidosisAndrew N Rosenbaum, Omar F AbouEzzeddine, Martha Grogan, et al.
Clinical Transplantation|July 13, 2018
Elevated ST2 levels are associated with antibody-mediated rejection in heart transplant recipientsAvishay Grupper, Omar F AbouEzzeddine, Joseph J Maleszewski, et al.
The American Journal of Medicine|March 28, 2017
Prognostic Value of Soluble ST2 After Myocardial Infarction: A Community PerspectiveWilliam S Jenkins, Véronique L Roger, Allan S Jaffe, et al.
Clinical Chemistry|July 3, 2014
High-sensitivity troponin I and amino-terminal pro--B-type natriuretic peptide predict heart failure and mortality in the general populationPaul M McKie, Omar F AbouEzzeddine, Christopher G Scott, et al.
Pageof 5

Showing results (1-10 of 49) with videos related to

Sort By:
Pageof 5
Congestive Heart Failure (Greenwich, Conn.)|July 28, 2011
Who has advanced heart failure?: definition and epidemiologyOmar F Abouezzeddine, Margaret M Redfield
Frontiers in Neurology|February 19, 2021
Chloroquine and Hydroxychloroquine Myopathy: Clinical Spectrum and Treatment OutcomesElie Naddaf, Pritikanta Paul, Omar F AbouEzzeddine
Plos One|August 17, 2018
High-sensitivity C-reactive protein in heart failure with preserved ejection fractionHilary M DuBrock, Omar F AbouEzzeddine, Margaret M Redfield
The Quarterly Journal of Nuclear Medicine and Molecular Imaging : Official Publication of the Italian Association of Nuclear Medicine (AIMN) [And] the International Association of Radiopharmacology (IAR), [And] Section of the Society Of|January 30, 2020
Imaging cardiac sarcoidosis and infiltrative diseases: diagnosis and therapeutic responseMohamed Y Elwazir, John P Bois, Omar F Abouezzeddine, et al.
Internal and Emergency Medicine|May 17, 2026
Novelty to necessity: large language models in clinical practice-a call to action for physiciansVittorio Beltrani, Olivier Giannini, Omar F AbouEzzeddine, et al.
Biomarkers : Biochemical Indicators of Exposure, Response, and Susceptibility to Chemicals|July 16, 2021
Sex-specific cut-off values for soluble suppression of tumorigenicity 2 (ST2) biomarker increase its cardiovascular prognostic value in the communityDavid M Harmon, Omar F AbouEzzeddine, Paul M McKie, et al.
Transplantation|April 21, 2018
Outcomes After Cardiac Transplant for Wild Type Transthyretin AmyloidosisAndrew N Rosenbaum, Omar F AbouEzzeddine, Martha Grogan, et al.
Clinical Transplantation|July 13, 2018
Elevated ST2 levels are associated with antibody-mediated rejection in heart transplant recipientsAvishay Grupper, Omar F AbouEzzeddine, Joseph J Maleszewski, et al.
The American Journal of Medicine|March 28, 2017
Prognostic Value of Soluble ST2 After Myocardial Infarction: A Community PerspectiveWilliam S Jenkins, Véronique L Roger, Allan S Jaffe, et al.
Clinical Chemistry|July 3, 2014
High-sensitivity troponin I and amino-terminal pro--B-type natriuretic peptide predict heart failure and mortality in the general populationPaul M McKie, Omar F AbouEzzeddine, Christopher G Scott, et al.
Pageof 5